Identification of human parvovirus B19 among measles and rubella suspected patients from Cuba
María de Los Ángeles Ribas1, Yahisel Tejero1, Yanislet Cordero1
1Virology Department, National Reference Laboratory of Measles, Mumps, Rubella, Pedro Kourí Institute of Tropical Medicine, Havana, Cuba.
Abstract:
Between September 2014 and December 2015, 298 sera from rash and fever patients from all over Cuba were investigated for specific IgM antibodies against measles, rubella, dengue, human parvovirus B19 (B19V) and human herpesvirus 6 (HHV6) using a commercial enzyme-linked immunosorbent assay kits. B19V IgM positive and equivocal samples were investigated by a polymerase chain reaction and genotyping. No measles, rubella or dengue cases were detected. HHV6-IgM antibodies were confirmed in 5.7% and B19V-IgM antibodies in 10.7% of the patients. A total of 31.3% of the B19V cases were between 5 and 9 years old and 34.4% were 20 years and older. The only B19V sequence obtained belonged to genotype 1a. Diagnosis was established for only 16% of the rash and fever patients, suggesting that other diseases such as Zika or Chikungunya may play a role.
Related Concept Videos
Methods of Classification and Identification
Patient-centered Care
Drug Dosing: Obese Patients
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Drug Dosing: Geriatric Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution


